Skip to content

Clinical trials

Terminated Phase 3 Myocardial Infarction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Status: Terminated Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20061
20073
20092
20101
20111
20132
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Pfizer2
Arginox Pharmaceuticals1
Axio Research. LLC1
CardioKinetix, Inc1
Cogentus Pharmaceuticals1
Hospital El Cruce1
M.D. Anderson Cancer Center1
Medstar Health Research Institute1
Miltenyi Biotec B.V. & Co. KG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction15
Cardiovascular Diseases5
Stroke5
Acute Coronary Syndrome3
Myocardial Ischemia3
ST Elevation Myocardial Infarction3
Atherosclerosis2
Coronary Artery Disease2
Hyperlipidemias2
Non-ST Elevated Myocardial Infarction2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.